These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31502315)

  • 1. Ten-year trends in catheter ablation for ventricular tachycardia vs other interventional procedures in Australia.
    Anderson RD; Lee G; Prabhu M; Patrick CJ; Trivic I; Campbell T; Chow CK; Kalman JM; Kumar S
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2353-2361. PubMed ID: 31502315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia.
    Kumar S; Walters TE; Halloran K; Morton JB; Hepworth G; Wong CX; Kistler PM; Sanders P; Kalman JM
    Europace; 2013 Dec; 15(12):1702-9. PubMed ID: 23796617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures.
    Eckardt L; Doldi F; Anwar O; Gessler N; Scherschel K; Kahle AK; von Falkenhausen AS; Thaler R; Wolfes J; Metzner A; Meyer C; Willems S; Köbe J; Lange PS; Frommeyer G; Kuck KH; Kääb S; Steinbeck G; Sinner MF
    Europace; 2023 Dec; 26(1):. PubMed ID: 38102318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in percutaneous pericardial access during catheter ablation of ventricular arrhythmias: a single-center experience.
    Killu AM; Sugrue AM; Mulpuru SK; McLeod CJ; Hodge DO; Noseworthy PA; Fanning L; Munger TM; Packer DL; Asirvatham SJ; Friedman PA
    J Interv Card Electrophysiol; 2016 Oct; 47(1):109-115. PubMed ID: 27193315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation.
    Reichlin T; Lockwood SJ; Conrad MJ; Nof E; Michaud GF; John RM; Epstein LM; Stevenson WG; Jarolim P
    J Interv Card Electrophysiol; 2016 Oct; 47(1):69-74. PubMed ID: 26971332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide survey on the current practice of ventricular tachycardia ablation.
    Vergara P; Casella M; Barbato G; De Ruvo E; Grandinetti G; Notarstefano P; Tola G; Calvi V; Santini L; Nissardi V; Nonis A; Ricci RP; Boriani G; Tondo C; Della Bella P
    J Cardiovasc Med (Hagerstown); 2019 Sep; 20(9):597-605. PubMed ID: 31318839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Rozen G; Elbaz-Greener G; Marai I; Andria N; Hosseini SM; Biton Y; Heist EK; Ruskin JN; Gavrilov Y; Carasso S; Ghanim D; Amir O
    J Am Heart Assoc; 2020 Jul; 9(13):e015721. PubMed ID: 32573325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in referral, procedures, and outcome after ablation for atrial fibrillation in Europe: a report from the Atrial Fibrillation Ablation Pilot Registry of the European Society of Cardiology.
    Riahi S; Arbelo E; Brugada J; Maggioni AP; Tavazzi L; Vardas P; Laroche C; Efremidis M; Xhaet O; Woźniak A; Van Gelder IC; Hjortshoj S
    Europace; 2016 Feb; 18(2):191-200. PubMed ID: 26647447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronary artery disease and revascularization on recurrence of atrial fibrillation after catheter ablation: Importance of ischemia in managing atrial fibrillation.
    Hiraya D; Sato A; Hoshi T; Watabe H; Yoshida K; Komatsu Y; Sekiguchi Y; Nogami A; Ieda M; Aonuma K
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1491-1498. PubMed ID: 31190437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Completely nonfluoroscopic catheter ablation of left atrial arrhythmias and ventricular tachycardia.
    Sadek MM; Ramirez FD; Nery PB; Golian M; Redpath CJ; Nair GM; Birnie DH
    J Cardiovasc Electrophysiol; 2019 Jan; 30(1):78-88. PubMed ID: 30203499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation in adults with congenital heart disease: A 15-year perspective from a tertiary centre.
    Waldmann V; Amet D; Zhao A; Ladouceur M; Otmani A; Karsenty C; Maltret A; Ollitrault J; Pontnau F; Legendre A; Florens E; Munte L; Soulat G; Mousseaux E; Du Puy-Montbrun L; Lavergne T; Bonnet D; Vouhé P; Jouven X; Marijon E; Iserin L
    Arch Cardiovasc Dis; 2021; 114(6-7):455-464. PubMed ID: 33846095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database.
    Aryana A; d'Avila A; Cool CL; Miller MA; Garcia FC; Supple GE; Dukkipati SR; Lakkireddy D; Bunch TJ; Bowers MR; O'Neill PG; Reddy VY; Marchlinski FE
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1295-1302. PubMed ID: 28800178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant physician practice variability in the utilization of endovenous thermal ablation in the 2017 Medicare population.
    Mann M; Wang P; Schul M; Khilnani NM; Park A; Makary MA; Hicks CW
    J Vasc Surg Venous Lymphat Disord; 2019 Nov; 7(6):808-816.e1. PubMed ID: 31495766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portuguese National Registry on Cardiac Electrophysiology, 2017 and 2018.
    Cortez-Dias N; Silva Cunha P; Moscoso Costa F; Bonhorst D; M Oliveira M
    Rev Port Cardiol (Engl Ed); 2021 Feb; 40(2):119-129. PubMed ID: 33608198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study.
    D'Angelo RN; Khanna R; Yeh RW; Goldstein L; Kalsekar I; Marcello S; Tung P; Zimetbaum PJ
    BMC Cardiovasc Disord; 2020 Apr; 20(1):161. PubMed ID: 32252637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: Insights from 18,641 procedures performed over 12-year period.
    Landes U; Bental T; Levi A; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Greenberg G; Orvin K; Kornowski R
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):E262-E270. PubMed ID: 29027735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score-matched analysis of in-hospital outcomes in the United States.
    Briceño DF; Gupta T; Romero J; Kolte D; Khera S; Villablanca PA; Tran A; Mohanty S; Trivedi C; Mohanty P; Gianni C; Kim SG; Garcia M; Fonarow GC; Bhatt DL; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2018 May; 29(5):771-779. PubMed ID: 29399923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spanish Catheter Ablation Registry. 12th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2012).
    Ferrero de Loma-Osorio Á; Díaz-Infante E; Macías Gallego A;
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):983-92. PubMed ID: 24774111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of United States endovenous ablation practice trends from the Medicare Data Utilization and Payment Database.
    Crawford JM; Gasparis A; Almeida J; Elias S; Wakefield T; Lal BK; Osborne N; Amery S; Labropoulos N
    J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):471-479. PubMed ID: 31203856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.